TWi Biotechnology Inc Sustainability Reports
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the research, clinical development, and global licensing of repositioned or novel drugs for rare diseases, dermatological conditions, and central nervous system disorders.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG008B6X1C4
10 reports from 2016 to 2025